TABLE 1.
Median (range) | All patients (N = 20) | Left-sided (N = 15) | Right-sided (N = 5) |
Age at diagnosis | 50 (32–77) | 49 (35–77) | 52 (32–75) |
Age at MRI | 59 (40–84) | 58 (41–84) | 64 (40–80) |
Follow-up (years) | 8.3 (5.2–14.4) | 8.2 (5.7–13.9) | 8.5 (5.2–14.4) |
Receipt of Trastuzumab | 2 | 1 | 1 |
Smoking history ≥ 10 pack-year | 4 | 3 | 1 |
Cardiovascular disease | 0 | 0 | 0 |
Hypertension | 6 | 5 | 1 |
Hyperlipidemia | 6 | 6 | 0 |
Type II diabetes | 2 | 2 | 0 |
Patient characteristics and the presence of cardiovascular risk factors at the time of MRI are shown.